Background Although chest X-rays (CXRs) are widely used, diagnosing mitral stenosis (MS) based solely on CXR findings remains ...

A novel form of chest X-ray imaging could help clinicians detect pneumothorax more quickly and with greater confidence.

According to MarketsandMarketstm, the Oil and Gas NDT and Inspection Market is projected to expand steadily from USD 4.06 billion in 2025 to USD 6.20 billion by 2030 at a CAGR of 8.8%. Browse 160 ...

The global aerospace NDT market generated USD 1.84 billion in 2024 and is expected to grow from USD 1.97 billion in 2025 to approximately USD 3.65 billion by 2034, registering a CAGR of 7.10% over the ...

This combined model achieved a high level of accuracy, suggesting that imaging data alongside basic clinical information could be effective for screening.

The global non-destructive testing equipment market size was US$ 3,271.5 million in 2021. The global non-destructive testing equipment market is forecast to grow to US$ 6119.01 million by 2030 by ...

MISTRAS Group, Inc. has been selected by Bechtel to deliver non-destructive testing services for the Woodside Louisiana LNG ...

SMT Corp, a global leader in the sourcing and advanced testing of electrical, electronic, and electromechanical (EEE) ...

The project, which is permitted up to 27.6 million tonnes per annum of LNG production, is one of the most significant energy infrastructure developments in the world and represents a major investment ...

The agency said that although Akeega with prednisone improved outcomes in all patients with HRR mutations, the benefits were driven by those with BRCA2 mutations.

The FDA approved niraparib and abiraterone acetate plus prednisone for BRCA2-mutated mCSPC, based on the AMPLITUDE trial's rPFS results. FDA approves a new treatment combining niraparib and ...

Johnson & Johnson (NYSE:JNJ) announced today the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for AKEEGA® (niraparib and abiraterone acetate ...